Objective: This study was designed to evaluate the role of hemostatic variables in arterial blood serum in left atrial thrombosis and to define any hemostatic variables, such as serum biomarkers, that could potentially reduce the need for transesophageal echocardiography.
Methods: This study included patients with non-valvular asymptomatic atrial fibrillation (AF), either paroxysmal, persistent, or chronic. The presence of an left atrial appendix (LAA) thrombus was used to form 2 groups: thrombus (+) and thrombus (-). The serum levels of the thrombotic/fibrinolytic markers including beta-thromboglobulin, prothrombin fragment 1+2, thrombin/antithrombin complex, human plasminogen activator inhibitor-1/tissue plasminogen activator complex, and D-dimer were compared between 2 groups.
Results: The mean age of the study population was 65.6±12.2 years (range: 30-96 years), and 33 (61.1%) patients were male. Fourteen (25.9%) patients had an LAA thrombus and 40 patients did not. Two groups did not differ significantly with regard to any of the coagulation/fibrinolysis markers. The LAA thrombus (+) group had significantly higher rates of heart failure, peripheral artery disease, coronary artery disease, and chronic obstructive pulmonary disease (<0.05). Neither the serum levels of the study markers nor demographic and clinical parameters were predictive of an LAA thrombus in binary logistic regression analysis.
Conclusion: The arterial blood serum markers did not differ significantly between groups with and without an LAA thrombus and did not predict an LAA thrombus in patients presenting with AF.
Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.Stroke. 2016 Jul;47(7):1872-8. doi: 10.1161/STROKEAHA.116.012856. Epub 2016 Jun 14. Stroke. 2016. PMID: 27301942
Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation.BMC Cardiovasc Disord. 2018 Jul 31;18(1):153. doi: 10.1186/s12872-018-0889-y. BMC Cardiovasc Disord. 2018. PMID: 30064363 Free PMC article.
[Clinical characteristics of left atrial appendage thrombus in patients with hypertrophic cardiomyopathy and non-valvular atrial fibrillation].Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Dec 24;47(12):956-962. doi: 10.3760/cma.j.issn.0253-3758.2019.12.003. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 31877590 Chinese.
Circulating Galectin-3 is Associated With Left Atrial Appendage Remodelling and Thrombus Formation in Patients With Atrial Fibrillation.Heart Lung Circ. 2019 Jun;28(6):923-931. doi: 10.1016/j.hlc.2018.05.094. Epub 2018 May 14. Heart Lung Circ. 2019. PMID: 29861319 Clinical Trial.
Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure.Heart. 2012 Aug;98(15):1120-6. doi: 10.1136/heartjnl-2012-301799. Epub 2012 May 9. Heart. 2012. PMID: 22572045 Review.